Migdal Insurance & Financial Holdings Ltd. Rocket Pharmaceuticals, Inc. Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$39.41 - $47.25 $791,865 - $949,394	-20,093 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$43.34 - $65.91 $540,406 - $821,831	12,469 Added 163.55%	20,093 $892,000
Q4 2020 Feb 08, 2021	BUY	$23.3 - $59.57 $177,639 - $454,161	7,624 New	7,624 $418,000

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

Rtw Investments, LP New York, NY

17.7M
Shares

$250 Million
5.21% of portfolio
Wellington Management Group LLP Boston, MA

11.2M
Shares

$159 Million
0.04% of portfolio
Black Rock Inc. New York, NY

6.19M
Shares

$87.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.54M
Shares

$78.1 Million
0.0% of portfolio
Westfield Capital Management CO LP Boston, MA

4.49M
Shares

$63.4 Million
0.39% of portfolio

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account